Patent · US Active

Biomarkers for diagnosing alzheimer's disease

US8772042B2 · kind B2 · utility

9Cited by

1References

5Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Özkan Yalkinoglu · Wuppertal, DE
Gerhard Konig · Düsseldorf, DE
Denis Francois Hochstrasser · Geneva, CH
Jean-Charles Sanchez · Geneva, CH
Odile Carrette · Roubaix, FR

Key dates

Filing date	May 2, 2011
Grant date	Jul 8, 2014
Priority date	—
Expiry date	May 2, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2821
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific peptide markers, e.g., using mass spectrometric analysis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.